Skip to content
  • Facebook
  • X
  • Linkedin
  • WhatsApp
  • YouTube
  • Associate Journalism
  • About Us
  • Privacy Policy
  • 033-46046046
  • editor@artifex.news
Artifex.News

Artifex.News

Stay Connected. Stay Informed.

  • Breaking News
  • World
  • Nation
  • Sports
  • Business
  • Science
  • Entertainment
  • Lifestyle
  • Toggle search form
  • Access Denied Sports
  • Access Denied Business
  • IPL-17, LSG vs CSK | Simply owning that space, says Fleming of Dhoni
    IPL-17, LSG vs CSK | Simply owning that space, says Fleming of Dhoni Sports
  • Authorities As Japan’s Pilgrimage Site Flooded With Visitors
    Authorities As Japan’s Pilgrimage Site Flooded With Visitors World
  • Access Denied Business
  • A change not just in generation, but in culture too
    A change not just in generation, but in culture too Sports
  • Access Denied
    Access Denied Nation
  • Access Denied
    Access Denied Nation
SEBI rejects Digvijay Gaekwad’s plea for competing open offer in Religare deal

SEBI rejects Digvijay Gaekwad’s plea for competing open offer in Religare deal

Posted on February 14, 2025 By admin


Capital markets regulator Securities and Exchange Board of India (SEBI) on Friday (February 14, 2025) rejected Digvijay Laxhamsinh Gaekwad’s plea seeking an exemption to make a competing open offer for a majority stake in Religare Enterprises.

With this ruling, the Burman Group’s open offer process remains on track, solidifying their acquisition bid for Religare Enterprises Ltd (REL).

The market regulator in an order stated that the price offered by Mr. Gaekwad was ₹275 per share in the proposed open offer which was ₹40 higher than the Burman Group’s offer of ₹235 per share.

“The applicant (Danny Gaekwad Developments & Investments, Florida) has failed to demonstrate his ability to meet the financial obligation for making the competing open offer,” it stated.

SEBI also observed that the “applicant has failed to deposit ₹600 crore, as directed by the Supreme Court of India vide its order dated February 7, 2025, read with order dated February 12, 2025, which would have shown the applicant’s commitment towards making the competing open offer”.

In the absence of adequate proof of financial resources required for making the competing open offer, the application does not appear to be bonafide. It seems frivolous and aimed solely at hindering the open offer process, the order passed by SEBI’s whole-time member Ashwani Bhatia said.

“I …. dispose of the application dated February 1, 2025, filed by the applicant,” Ms. Bhatia said in the order.

The regulator in its order, noted that Mr. Gaekwad’s request did not qualify as an exemption under the norms since he was not seeking relief from making an open offer but rather permission to make a competing one against the Burman Group.

SEBI maintained that the Burman Group’s public announcement date remained September 25, 2023, as per rules, and not January 18, 2025, as contended by Mr. Gaekwad.

The regulator also emphasised that Mr. Gaekwad had not applied for necessary regulatory approvals from SEBI, RBI, or other authorities. Even if he did, the approval process would be time-consuming, leading to uncertainty and further delaying the open offer.

SEBI also questioned the role of Mr. Gaekwad’s merchant banker, PL Capital Markets Pvt. Ltd., in doing the due diligence while taking on the assignment of the competing open offer.

“The merchant banker was clueless about the credentials of Mr. Gaekwad and was found to have failed to do proper due diligence and KYC of his client before accepting the mandate,” the regulator said.

The markets watchdog also highlighted that the open offer process by the Burman Group was already underway, with over 2.31 lakh shares tendered as of February 13.

“If Mr. Gaekwad’s competing offer were permitted, those shareholders who had already tendered their shares would be unable to participate, creating an unfair situation,” the regulator said in the order.

SEBI said if the competing open offer is allowed to be made by the applicant, it would entail keeping the open offer process by the Burman Group on hold for an uncertain period in a situation where the decision of regulators on the competing open offer cannot even be predicted.

“The same shall not only be prejudicial to the interest of the Burman Group, an existing shareholder of the target company (REL), which has devoted considerable effort, time and resources to be able to make the open offer, but also to the shareholders who have already tendered shares in the open offer by Burman’s,” SEBI said.

The regulator noted that Burman Group is a stakeholder in this process and as a shareholder of the REL, is entitled to protection of its rights, just like other shareholders.

The order came after Mr. Gaekwad submitted a letter dated January 24, January 26 and February 1, to SEBI requesting to grant requisite exemption from strict enforcement of Regulation 20 of the SAST (Substantial Acquisition of Shares and Takeover) rules to allow him to make a competing offer for 55% stake of REL, at a price of ₹275 per equity share.

He had also sought a directive to keep the Burman Group’s open offer in abeyance.

Later, Mr. Gaekwad filed a formal application, and the matter reached the Delhi High Court seeking a stay on the Burman Group’s open offer.

The court, however, directed SEBI to decide on Mr. Gaekwad’s plea while allowing the Burman Group’s offer to proceed.

Dabur India promoter Burman family through its four entities – M.B. Finmart Pvt Ltd, Puran Associates, VIC Enterprises, and Milky Investment & Trading Company – held a 21.54% stake in REL and proposed to acquire an additional 5.27% from the market in September 2023, triggering an open offer requirement under SEBI’s Takeover rules.

Thereafter, a public announcement for the open offer was made on September 25, 2023, followed by a detailed public statement (DPS) on October 4, 2023.

The Burman Group have attempted to obtain the requisite regulatory approvals in order to discharge the open offer obligations under SAST rules, however, the management of REL failed to extend the required cooperation in this regard.

Consequently, SEBI, through an order dated June 19, 2024, directed REL to make necessary applications for obtaining the required regulatory approvals.

Subsequently, after grant of approval by SEBI and RBI in December 2024, the Burman Group proceeded with the open offer process.

However, regulatory approvals took time, and the open offer process could only commence in January this year with the tendering period scheduled from January 27 to February 7.

The SEBI order came a day after Religare Enterprises announced that its executive chairperson Rashmi Saluja ceased to be a director on its board following shareholders’ rejection of a proposal seeking her re-appointment.

Published – February 14, 2025 11:14 pm IST



Source link

Business Tags:acquisition bid for Religare Enterprises, Religare Enterprises, Securities and Exchange Board of India

Post navigation

Previous Post: Bangladesh will have a new political party, interim govt. official confirms to Ireland Ambassador 
Next Post: Clinical New Zealand Thump Pakistan To Win Tri-Nations Final

Related Posts

  • SBI reckons poverty levels between 4%-5%; inflation to ease if core inflation is declining vis-a-vis food price rise
    SBI reckons poverty levels between 4%-5%; inflation to ease if core inflation is declining vis-a-vis food price rise Business
  • Access Denied Business
  • Rupee turns flat at 83.03 against U.S. dollar in early trade
    Rupee turns flat at 83.03 against U.S. dollar in early trade Business
  • Stock markets close lower on fag-end selling as RBI changes stance to neutral
    Stock markets close lower on fag-end selling as RBI changes stance to neutral Business
  • Hindenburg Research: Allegations against Adani duly investigated; Madhabi Buch disclosed, recused when necessary, says SEBI
    Hindenburg Research: Allegations against Adani duly investigated; Madhabi Buch disclosed, recused when necessary, says SEBI Business
  • Sun Pharma to acquire U.S. firm Organon in .75 billion deal
    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal Business

More Related Articles

Access Denied Business
Access Denied Business
Access Denied Business
Access Denied Business
Lower Q2 GDP growth a temporary blip; economy to improve in coming quarters, says Nirmala Sitharaman Lower Q2 GDP growth a temporary blip; economy to improve in coming quarters, says Nirmala Sitharaman Business
Access Denied Business
SiteLock

Archives

  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022

Categories

  • Business
  • Nation
  • Science
  • Sports
  • World

Recent Posts

  • Gold ETF prices revive as investors flock on higher import duties on yellow metal
  • Assam ships first legal agarwood chips to West Asia
  • How the anti-defection law is going to operate in the AIADMK case?
  • ATS questions 57 in Maharashtra over alleged gangster network links
  • Nicobarese oppose proposal for three wildlife sanctuaries

Recent Comments

  1. Stevemonge on UP Teacher Who Asked Students To Slap Muslim Classmate
  2. RichardClage on UP Teacher Who Asked Students To Slap Muslim Classmate
  3. StevenLek on UP Teacher Who Asked Students To Slap Muslim Classmate
  4. Leonardren on UP Teacher Who Asked Students To Slap Muslim Classmate
  5. NathanQuins on UP Teacher Who Asked Students To Slap Muslim Classmate
  • Access Denied Sports
  • Access Denied Sports
  • Access Denied
    Access Denied Nation
  • Access Denied Sports
  • U.S. stock settlement switch could face an early resilience test
    U.S. stock settlement switch could face an early resilience test Business
  • Access Denied Business
  • Cricket World Cup 2023: Bangladesh’s Squad, Match Schedule, Top Performers
    Cricket World Cup 2023: Bangladesh’s Squad, Match Schedule, Top Performers Sports
  • On Jasprit Bumrah Missing Champions Trophy, BCCI Secretary’s Sharp Answer: “Team Combination…”
    On Jasprit Bumrah Missing Champions Trophy, BCCI Secretary’s Sharp Answer: “Team Combination…” Sports

Editor-in-Chief:
Mohammad Ariff,
MSW, MAJMC, BSW, DTL, CTS, CNM, CCR, CAL, RSL, ASOC.
editor@artifex.news

Associate Editors:
1. Zenellis R. Tuba,
zenelis@artifex.news
2. Haris Daniyel
daniyel@artifex.news

Photograher:
Rohan Das
rohan@artifex.news

Artifex.News offers Online Paid Internships to college students from India and Abroad. Interns will get a PRESS CARD and other online offers.
Send your CV (Subjectline: Paid Internship) to internship@artifex.news

Links:
Associate Journalism
About Us
Privacy Policy

News Links:
Breaking News
World
Nation
Sports
Business
Entertainment
Lifestyle

Registered Office:
72/A, Elliot Road, Kolkata - 700016
Tel: 033-22277777, 033-22172217
Email: office@artifex.news

Editorial Office / News Desk:
No. 13, Mezzanine Floor, Esplanade Metro Rail Station,
12 J. L. Nehru Road, Kolkata - 700069.
(Entry from Gate No. 5)
Tel: 033-46011099, 033-46046046
Email: editor@artifex.news

Copyright © 2023 Artifex.News Newsportal designed by Artifex Infotech.